HashiCorp Inc (HCP) concluded trading on Wednesday at a closing price of $34.33, with 4.55 million shares of worth about $156.31 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 2.91% during that period and on January 08, 2025 the price saw a gain of about 0.03%. Currently the company’s common shares owned by public are about 161.39M shares, out of which, 153.13M shares are available for trading.
Stock saw a price change of 0.35% in past 5 days and over the past one month there was a price change of 1.63%. Year-to-date (YTD), HCP shares are showing a performance of 0.35% which increased to 53.12% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $20.89 but also hit the highest price of $34.40 during that period. The average intraday trading volume for HashiCorp Inc shares is 1.92 million. The stock is currently trading 0.67% above its 20-day simple moving average (SMA20), while that difference is up 1.17% for SMA50 and it goes to 4.59% higher than SMA200.
HashiCorp Inc (NASDAQ: HCP) currently have 161.39M outstanding shares and institutions hold larger chunk of about 61.29% of that.
The stock has a current market capitalization of $7.02B and its 3Y-monthly beta is at 1.19. It has posted earnings per share of -$0.61 in the same period. It has Quick Ratio of 3.66 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for HCP, volatility over the week remained 0.46% while standing at 0.48% over the month.
Stock’s fiscal year EPS is expected to rise by 537.50% while it is estimated to increase by 36.33% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Citigroup on September 03, 2024 offering a Neutral rating for the stock and assigned a target price of $35 to it. On March 19, 2024, KeyBanc Capital Markets Initiated their recommendations, while on March 12, 2024, Scotiabank Upgrade their ratings for the stock with a price target of $31. Stock get an Overweight rating from Morgan Stanley on February 26, 2024.
